JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, A. S.
Right arrow Articles by Wilcox, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, A. S.
Right arrow Articles by Wilcox, G. L.

Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord

AS Hwang and GL Wilcox

Department of Pharmacology, University of Minnesota Medical School, Minneapolis.

Antinociceptive effects of baclofen, a gamma-aminobutyric acidB (GABAB) agonist, were studied in mice along with other GABAergic agents, all administered intrathecally (i.t.): i.e., muscimol (GABAA agonist), bicuculline (GABAA antagonist) and 5-aminovaleric acid (GABAB antagonist). After i.t. administration, none of the four compounds increased the withdrawal latency in the tail-flick test. With the intradermal hypertonic saline (6% saline) behavioral test, baclofen decreased the number of behaviors in a dose-dependent and 5- aminovaleric acid-reversible manner, whereas i.t. administered muscimol was ineffective. With the i.t. substance P (SP) behavioral test, muscimol was again ineffective, whereas the SP-induced behaviors were differentially modified by baclofen depending on the temporal order of their i.t. administration. Although baclofen, coadministered with SP, decreased the number of SP-induced behaviors, baclofen pretreatment (2- 100 min before i.t. administration of SP) increased the number of behaviors in a dose-dependent and 5-aminovaleric acid-reversible manner. Two minutes after several fixed doses of baclofen were administered i.t., dose-response curves for induction of behaviors by SP (i.t.) were shifted progressively to the left by increasing doses of baclofen, suggesting that hypersensitivity to SP had developed during this time frame. Decreased responsiveness to a peripheral noxious stimulus (hypertonic saline-induced behavior) is therefore associated with hypersensitivity to i.t. applied SP (SP behavioral test). The selective action of a GABAB agonist on neurokinin-elicited behaviors shown in this study is in clear contrast to the selective action of a GABA agonist against excitatory amino acid spinal activity noted in the following paper.

Volume 248, Issue 3, pp. 1026-1033, 03/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. M. Laughlin, K. V. Tram, G. L. Wilcox, and A. K. Birnbaum
Comparison of Antiepileptic Drugs Tiagabine, Lamotrigine, and Gabapentin in Mouse Models of Acute, Prolonged, and Chronic Nociception
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1168 - 1175.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics.